Hiranmoy Das, PhD, currently a Professor in the Department of Biomedical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, Amarillo, Texas, USA. Dr. Das earned his BS (Hons), MS, and Ph.D. from Calcutta University, West Bengal, India. He received his postdoctoral training from Hyogo Adult Medical Center, Hyogo, Japan, and from the Department of Internal Medicine at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. Prior to his arrival at TTUHSC in Amarillo, Dr. Das served as an Associate Professor for the Department of Internal Medicine at The Ohio State University, as an Assistant Professor for the Case Western Reserve University’s Cardiovascular Research Institute in Cleveland, and as an Instructor in Medicine for Harvard Medical School, Boston, MA. Dr. Das’ current research focuses on isolating and expanding a variety of human adult stem cells and using them for the treatment of various degenerative diseases in preclinical models, like hind limb ischemia, myocardial ischemia, osteoporosis and wound healing. Dr. Das also utilizes human immune cells, specifically, gamma delta T-cells in immunotherapy, for treating various cancers (breast, ovary and others) using preclinical models. In addition, he investigates the role of transcriptional factor KLF2 in regulating immune cells, specifically monocytes, in rheumatoid arthritis and inflammation. Dr. Das also serves as a member of the editorial board for several peer-reviewed journals and serves on the grant review panels of various state, national and international funding agencies.
Interests
- Arthritis
- Cancer
- Cell biology
- Cornea surgery
- Hematology
- Parkinson's disease
- Rheumatoid arthritis
Pharmacy Research Interests
- NFkB
- Ovarian Cancer
- Parkinson's Disease
- T Cells
- animal models
- cancer
- cancer biology
- cancer immunotherapy
- cardiovascular
- cell signaling
- diabetes
- hematology and oncology
- immunotherapy
- innate immunity
- myocardial infarction
- osteoporosis
- signal transduction
- stem cell
- translational medicine
- tumor immunology